NovaBridge Biosciences (NBP): Total Liabilities
Older than the company's other figures. The latest Total Liabilities is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
894.81M CNY
As of 2023-12-31
+8.2%
3-year compound annual growth
+16.6%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | 894.81M CNY | -23.1% | 2024-04-30, Balance as of period end |
| 2022-12-31 | 1.16B CNY | +11.7% | 2024-04-30, Balance as of period end |
| 2021-12-31 | 1.04B CNY | +47.4% | 2023-05-01, Balance as of period end |
| 2020-12-31 | 706.65M CNY | +5.8% | 2022-04-29, Balance as of period end |
| 2019-12-31 | 668.09M CNY | +60.7% | 2021-04-28, Balance as of period end |
| 2018-12-31 | 415.68M CNY | n/a | 2020-04-29, Balance as of period end |